Home Superbug News

Superbug News

The Superbug Stock Review. Deadly Antibiotic-Resistant Bacteria like ‘Candida Auris’ and Deadly and Virulent Viruses Like ‘CoronaVirus’ or ‘HIV’ which killed 32 million. If Wall Street’s Funded Biotechs Are Trying to Kill What Wants to Kill Us, We’ll Follow It.

Internet Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:

Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz Don't Be That Guy in Denial!

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was Eradicated.

During the 20th century, it is estimated that smallpox was responsible for 300–500 million deaths. In the early 1950s, an estimated 50...
AR THreats Report, Biotech Stock Reciew

AR Threats Report (CDC)

This report is dedicated to the 48,700 familieswho lose a loved one each year to antibiotic resistanceor Clostridioides difficile, and the...

Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.
Citius Pharmaceutical, CTXR, Biotech Stock Review

Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
coronavirus stocks

Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on 180 Million Shares!

We've played many sector manias in the past (operative word 'play') such as solar, stem cells, restaurants, blockchain, marijuana, and patent monetization...
Immuron, Superbug Stock Review

Adding Immuron (IMRN) $2.57 to Superbug Watchlist.

CLICK FOR LIVE QUOTE SUPER BUG STOCK REVIEW
Immuron, IMRN

Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!

Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd ...
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...

Latest article

Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.

VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
Citius Pharma

Citius Pharma (CTXR) On The Move.

One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want...
Biotech Stock Review

Meet The Billion-Dollar Family Company That Makes Purell (Forbes).

Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946. Forbes 3/20/2020 Panic buying is...